欧洲 · 通讯社与实时数据 · Reuters
Novo loses share in Brazil to cheaper generics, but holds up in Canada and India
Novo Nordisk is losing market share in Brazil after its semaglutide patent expired, driving a 3% decline in emerging market sales in the third quarter, CEO Mike Doustdar told…
在 Reuters 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.reuters.com)
